Hema Now
In this episode of Hema Now, we sit down with Toby Eyre, Consultant Haematologist at Oxford University Hospitals, to explore the latest advances in lymphoma and CLL, discuss unanswered questions in mantle cell lymphoma, and consider how emerging research is shaping the future of lymphoma care.

Toby Eyre is a Consultant Haematologist at Oxford University Hospitals NHS Foundation Trust, specialising in the management of lymphoid malignancies, including lymphoma and chronic lymphocytic leukaemia. His research interests include clinical trials, novel targeted therapies, biomarkers and the management of complex lymphoid malignancies.
Timestamps:
00:00 – Distinguishing practice-changing data from early findings
01:38 – Research achievements and patient impact
04:38 – Raising awareness of blood cancers
08:45 – Advice for early-career haematologists
10:20 – Three wishes for future care
Disclaimer: The opinions expressed in this episode belong to the speakers and do not necessarily represent the opinions of EMJ.




